<DOC>
	<DOCNO>NCT02852681</DOCNO>
	<brief_summary>This single-center , open-label , randomize , balance , single-dose , two-treatment , two-period , two-sequence crossover study conduct medical supervision 28 healthy female volunteer .</brief_summary>
	<brief_title>Effect Food Bioavailability 15 mg Estetrol/3 mg Drospirenone Tablets Healthy Female Volunteers</brief_title>
	<detailed_description>Food effect bioavailability study usually conduct new drug drug product assess effect food rate extent absorption drug drug product administer shortly meal ( fed condition ) , compare administration fast condition . Therefore , study design characterize effect high fat meal bioavailability E4 DRSP administration single tablet contain 15 mg E4 3 mg DRSP . All subject enter study site least 12 hour dose fast least 10 hour prior dose . All subject receive Treatment A ( Reference ; single 15 mg E4/3 mg DRSP tablet without food ( fast ) ) Treatment B ( Test ; single 15 mg E4/3 mg DRSP tablet food ( feed ) ) either first treatment period ( Period 1 ) second treatment period ( Period 2 ) . Approximately half subject randomize receive either Treatment A follow Treatment B ( Sequence AB ) , Treatment B follow Treatment A ( Sequence BA ) .</detailed_description>
	<mesh_term>Drospirenone</mesh_term>
	<criteria>Overtly healthy female . Between age 18 45 year , inclusive . Nonsmokers use tobacco nicotine form 3 month prior screen visit . Between body mass index ( BMI ) 18 30 kg/m2 , inclusive , body weight 45kg . Negative serum pregnancy test result screen negative urine pregnancy test result dose . Willing use doublebarrier method nonhormonal contraception entire study period . Potential study subject enter and/or may discontinue study follow apply : Use progestogenonly contraceptive method [ e.g. , minipill , implant , intrauterine system ( IUS ) ] last 3 month prior first dose , depot progestogen preparation injectable hormonal method contraception ( e.g. , DepoProvera ) last 6 month prior first dose . Use ( within 28 day prior first dose ) hormonal contraceptive method . Use prescription drug ( except thyroid hormone supplement ) herbal supplement act CYP3A4 function ( e.g. , St. John 's Wort ) , within 28 day prior first dose study completion , overthecounter ( OTC ) medication ( include paracetamol ) dietary supplement ( vitamin include ) within 14 day prior first study dose study completion .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>